Amsel Medical Announces Expanded Medical Advisor Group
Experienced team brings track record of quality product counsel for growth
Cambridge, Mass. -- Amsel Medical Corp. today announced the expansion of its medical advisory team as the company advances the current product commercialization phase to address the demand for minimally invasive, simple and secure occlusion.
Joining the advisory team are -
- Col. John Dorsch, DO, USAF, Retired; prior wing surgeon, physician, and medical officer for the 24th Special Operations Wing (Air Force Special Operations Command) and Air Force Pararescue Medical Director
- Joshua Hazelton, DO, Trauma Medical Director, Associate Professor of Surgery and Section Chief of Trauma at Penn State Health
- Thomas Proebstle, MD, Professor of Dermatology for the Department of Dermatology, Mainz University Medical Center and founder of Private Clinic Proebstle
They will join existing advisors -
- Thomas O’Donnell, MD, former CEO and President of Tufts Medical Center
- Elazer R. Edelman, MD, professor at Massachusetts Institute of Technology and Harvard Medical School and Senior Attending Physician Brigham and Women’s Hospital
- Steven Schwaitzberg, MD, Chair of Surgery at the University of Buffalo
“These physicians represent a team of leading authorities in their respective fields who understand the clinical and patient needs, the demands on physicians and have successful track records helping bring innovative clinical solutions to market,” said Amsel Medical CEO David Doster. “We are proud and excited to have them on board and to invest their expertise in the path we are pursuing today.”
Amsel Medical’s SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures including ducts – for surgical and interventional procedures.
About Amsel Medical Corporation
Amsel Medical Corporation is a medical device venture delivering simple and secure technology for vessel and duct occlusion. Its CE mark and FDA cleared SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures like ducts – for surgical and interventional procedures. The unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasive, 18G needle. iDOT’s anchoring feature secures the implant in place and eliminates slippage. Its Grasping feature allows physicians to occlude vessels of varying sizes, types and wall thickness.
Related news
-
Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients
Intermountain Primary Children’s Hospital First in the Country to Implant this Next Generation FDA-Cleared Device Company Welcomes Vice President of Sales & Marketing, Mark Geiger, Who Lives with Hydrocephalus Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, is pleased to announce the successful first implant of the Company’s...
-
7-year-old Boy Managing His Hydrocephalus with ReFlow Ventricular System “Gen 1” Featured on Charleston’s ABC News 4
After struggling to conceive a child for what felt like ages, Miranda of Moncks County, South Carolina finally fell pregnant - a miracle that quickly turned into horror when she delivered at 24 weeks in late 2015. At just 1 pound and 12 ounces, her son, Sutton, arrived with life-threatening health issues, including hydrocephalus - a neurological disorder caused by an abnormal buildup of cerebrospinal fluid in the brain that affects more than one million Americans.
-
NICE Irreversible Electroporation for Treating Prostate Cancer Announcement
Around half of all men say lack of sexual function is a significant problem to them after prostate cancer intervention, highlighted in an international survey from 32 countries and over 5000 men by the Europa-Uomo group1. Real world evidence is important to understand what is happening to patients in healthcare2, so AngioDynamics welcomed the news last week that the UK’s National Institute for Health and Care Excellence (NICE) Interventional Procedures Advisory Committee (IPAC) upgraded the guidance for...
-
Best HIFU ultrasound facelift machine for medical aesthetic
Today, the medical aesthetic industry has developed to make people more comfortable and safe in their pursuit of beauty. Among the many medical aesthetic procedures available, the best HIFU machine professional is a popular one. It is based on high intensity focused ultrasound technology and provides amazing aesthetic results. This article will reveal the magic of HIFU in a number of sections. Bvlaser is a ODM face lift HIFU machine manufacturer, we have HIFU vaginal tightening machine for sale. Principles of...
-
Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion
Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related macular degeneration (nAMD) and phase II/III PHOTON trial in diabetic macular edema (DME) QUASAR is expected to enroll around 800 patients in 27 countries Study will add to the robust development program for aflibercept 8 mg, exploring the potential to achieve visual...
Customer comments
No comments were found for Amsel Medical Announces Expanded Medical Advisor Group. Be the first to comment!